UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5132-5139

2010

Volltextzugriff (PDF)

Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial

The lancet oncology, 2013-03, Vol.14 (3), p.228-235

2013

Volltextzugriff (PDF)

Improved Detection of Five Major Gastrointestinal Pathogens by Use of a Molecular Screening Approach

Journal of Clinical Microbiology, 2010-11, Vol.48 (11), p.4140-4146

2010

Volltextzugriff (PDF)

Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1067-1074

2011

Volltextzugriff (PDF)

Detection of Campylobacter Species and Arcobacter butzleri in Stool Samples by Use of Real-Time Multiplex PCR

Journal of Clinical Microbiology, 2013-01, Vol.51 (1), p.253-259

2013

Volltextzugriff (PDF)

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2123-2127

2013

Volltextzugriff (PDF)

Incidence, clinical implications and impact on public health of infections with Shigella spp. and entero-invasive Escherichia coli (EIEC): results of a multicenter cross-sectional study in the Netherlands during 2016-2017

BMC infectious diseases, 2019-12, Vol.19 (1), p.1037-1037, Article 1037

2019

Volltextzugriff (PDF)

Current usage of pembrolizumab in triple negative breast cancer (TNBC)

Expert review of anticancer therapy, 2024-05, Vol.24 (5), p.253-261

2024

Volltextzugriff (PDF)

Streptococcus pneumoniae DNA Load in Blood as a Marker of Infection in Patients with Community-Acquired Pneumonia

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3308-3312

2009

Volltextzugriff (PDF)

The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer

Medical journal of Australia, 2013-08, Vol.199 (3), p.205-208

2013

Volltextzugriff (PDF)

High detection rates of enteropathogens in asymptomatic children attending day care

PloS one, 2014-02, Vol.9 (2), p.e89496-e89496

2014

Volltextzugriff (PDF)

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures

Asia-Pacific journal of clinical oncology, 2017-08, Vol.13 (4), p.266-276

2017

Volltextzugriff (PDF)

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4431-4437

2007

Volltextzugriff (PDF)

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

Clinical cancer research, 2004-05, Vol.10 (10), p.3386-3395

2004

Volltextzugriff (PDF)

A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2013-03, Vol.8 (3), p.329-337

2013

Volltextzugriff (PDF)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer

Breast cancer research and treatment, 2012-08, Vol.135 (1), p.241-252

2012

Volltextzugriff (PDF)

Does immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?

Breast (Edinburgh), 2013-02, Vol.22 (1), p.64-69

2013

Volltextzugriff (PDF)

CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care

Asia-Pacific journal of clinical oncology, 2021-01, Vol.17 (S1), p.3-14

2021

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1041-1048

2017

Volltextzugriff (PDF)

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Breast cancer research and treatment, 2023-02, Vol.198 (1), p.67-74

2023

Volltextzugriff (PDF)

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid

Cancer, 2013-02, Vol.119 (4), p.832-838

2013

Volltextzugriff (PDF)

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer

Clinical breast cancer, 2022-12, Vol.22 (8), p.792-800

2022

Volltextzugriff (PDF)

A new era of improving progression-free survival with dual blockade in postmenopausal HR+ , HER2− advanced breast cancer

Cancer treatment reviews, 2015-02, Vol.41 (2), p.94-104

2015

Volltextzugriff (PDF)

A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors

Breast cancer research and treatment, 2016-04, Vol.156 (2), p.319-330

2016

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(126)

Sprache

Englisch
(125)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial

Improved Detection of Five Major Gastrointestinal Pathogens by Use of a Molecular Screening Approach

Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial

Detection of Campylobacter Species and Arcobacter butzleri in Stool Samples by Use of Real-Time Multiplex PCR

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy

Incidence, clinical implications and impact on public health of infections with Shigella spp. and entero-invasive Escherichia coli (EIEC): results of a multicenter cross-sectional study in the Netherlands during 2016-2017

Current usage of pembrolizumab in triple negative breast cancer (TNBC)

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial

Streptococcus pneumoniae DNA Load in Blood as a Marker of Infection in Patients with Community-Acquired Pneumonia

The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer

High detection rates of enteropathogens in asymptomatic children attending day care

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer

Does immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?

CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care

Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer

A new era of improving progression-free survival with dual blockade in postmenopausal HR+ , HER2− advanced breast cancer

A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors

Aktive Filter

Suchergebnisse filtern